Overview

Ayahuasca, Esketamine and PTSD

Status:
RECRUITING
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.
Phase:
PHASE2
Details
Lead Sponsor:
University of Sao Paulo
Treatments:
Esketamine